Implications of new technology for infectious diseases practice

Clinical Infectious Diseases

Volumn 43, Issue 10, 2006, Pages 1318-1323

  Baron, Eilen Jo ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; RIBOSOME RNA;

ANALYTICAL ERROR; ASSAY; BACTERIAL GENOME; BINDING SITE; COST CONTROL; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DNA VIRUS; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE COST; HUMAN; INFECTION; MEDICAL EXPERT; MEDICAL INSTRUMENTATION; MEDICAL TECHNOLOGY; MICROBIOLOGY; MONEY; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REIMBURSEMENT; RELIABILITY; REVIEW; RNA VIRUS; SEQUENCE ANALYSIS; VALIDATION PROCESS;

BACTERIA; COMMUNICABLE DISEASES; DNA PROBES; HUMANS; MICROARRAY ANALYSIS; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUSES;

EID: 33750701876     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508536     Document Type: Review

References (50)

1. Tenover FC. DNA probes for infectious diseases. Boca Raton, FL: CRC Press, 1989.
2. Relman DA, Wright A. Molecular and cellular microbiology: new tools of the trade. Curr Opin Microbiol 1998; 1:337-9.
3. Baselski V, Buchanan K, Carey R, Clarridge J, Weissfeld A. Survey of clinical microbiology laboratory workloads, productivity rates, and staffing vacancies. Washington, DC: American Society for Microbiology Office of Public and Scientific Affairs, 2005.
4. Whitley RJ, Kimberlin DW. Herpes simplex encephalitis: children and adolescents. Semin Pediatr Infect Dis 2005; 16:17-23.
5. Elder BL, Hansen SA, Kellogg JA, Marsik FJ, Zabransky RJ. Cumitech 31 - verification and validation of procedures in the clinical microbiology laboratory. Washington, DC: ASM Press, 1997.
6. Mulawski K, Madej R, Ferrero D, et al. Verification of infectious disease molecular assays: a self-study module (CD-ROM or web-based). Atlanta: National Laboratory Training Network, CDC, 2005.
7. Xie Z, Pang YS, Liu J, et al. A multiplex RT-PCR for detection of type A influenza virus and differentiation of avian H5, H7, and H9 hemagglutinin subtypes. Mol Cell Probes 2006; 20:245-9.
8. Chonmaitree T, Menegus MA, Powell KR. The clinical relevance of 'CSF viral culture': a two-year experience with aseptic meningitis in Rochester, NY. JAMA 1982; 247:1843-7.
9. Satya M, Tholath J, Zhang J, Robinson C, Danielson S, Weir F. A rapid and highly accurate assay for the detection of enterovirus infections in cerebrospinal fluid samples using the GeneXpert Dx system [abstract C-291]. In: Program and abstracts of the American Society for Microbiology General Meeting (Orlando, FL). Washington, DC: American Society for Microbiology, 2006.
10. Swanson P, de Mendoza C, Joshi Y, et al. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol 2005; 43:3860-8.
11. Shafer MA, Moncada J, Boyer CB, Betsinger K, Flinn SD, Schachter J. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test. J Clin Microbiol 2003; 41:4395-9.
12. Koumans EH, Black CM, Markowitz LE, et al. Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid pap smear medium. J Clin Microbiol 2003; 41:1507-11.
13. Conraths FJ, Schares G. Validation of molecular-diagnostic techniques in the parasitological laboratory. Vet Parasitol 2006; 136:91-8.
14. Hoorfar J, Wolffs P, Radstrom P. Diagnostic PCR: validation and sample preparation are two sides of the same coin. APMIS 2004; 112:808-14.
15. Gilpin CM, Dawson DJ, O'Kane G, Armstrong JG, Coulter C. Failure of commercial ligase chain reaction to detect Mycobacterium tuberculosis DNA in sputum samples from a patient with smear-positive pulmonary tuberculosis due to a deletion of the target region. J Clin Microbiol 2002; 40:2305-7.
16. Culler EE, Caliendo AM, Nolte FS. Reproducibility of positive test results in the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2003; 41:3911-4.
17. Jorgensen JH, Salinas JR, Paxson R, Magnon K, Patterson JE, Patterson TF. False-positive Gen-Probe direct Mycobacterium tuberculosis amplification test results for patients with pulmonary M. kansasii and M. avium infections. J Clin Microbiol 1999; 37:175-8.
18. Seed CR, Kitchen A, Davis TM. The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transfus Med Rev 2005; 19:229-40.
19. Jastania R, Geddie WR, Chapman W, Boerner S. Characteristics of apparently false-negative digene hybrid capture 2 high-risk HPV DNA testing. Am J Clin Pathol 2006; 125:223-8.
20. Kellogg JA, Bankert DA, Manzella JP, Parsey KS, Scott SL, Cavanaugh SH. Occurrence and documentation of low-level bacteremia in a community hospital's patient population. Am J Clin Pathol 1995; 104:524-9.
21. Chui L, Drebot M, Andonov A, Petrich A, Glushek M, Mahony J. Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods. Diagn Microbiol Infect Dis 2005; 53:47-55.
22. Fredricks DN, Smith C, Meier A. Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR. J Clin Microbiol 2005; 43:5122-8.
23. Baron EJ, Carroll KC. Rapid diagnosis of tuberculous meningitis: what is the optimal method? Infections in Medicine 2005; 22:633-7.
24. Thwaites GE, Caws M, Chau TT, et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol 2004; 42:996-1002.
25. Stewart SM. The bacteriological diagnosis of tuberculous meningitis. J Clin Pathol 1953; 6:241-2.
26. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM Jr. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2003; 3:633-43.
27. Liu C, Song Y, McTeague M, Vu AW, Wexler H, Finegold SM. Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. FEMS Microbiol Lett 2003; 222:9-16.
28. Wang L, Qu W, Reeves PR. Sequence analysis of four Shigella boydii O-antigen loci: implication for Escherichia coli and Shigella relationships. Infect Immun 2001; 69:6923-30.
29. Fredricks DN, Jolley JA, Lepp PW, Kosek JC, Relman DA. Rhinosporidium seeberi: a human pathogen from a novel group of aquatic protistan parasites. Emerg Infect Dis 2000; 6:273-82.
30. Lo SC, Levin L, Ribas J, et al. Lack of serological evidence for Mycoplasma fermentans infection in army Gulf War veterans: a large scale case-control study. Epidemiol Infect 2000; 125:609-16.
31. Katseni VL, Gilroy CB, Ryait BK, et al. Mycoplasma fermentans in individuals seropositive and seronegative for HIV-1. Lancet 1993; 341:271-3.
32. Hakkarainen K, Jansson E, Ranki A, Valle SL, Krohn KJ. Serological responses to mycoplasmas in HIV-infected and non-infected individuals. AIDS 1992; 6:1287-92.
33. Morre SA, Sillekens PT, Jacobs MV, et al. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification. Mol Pathol 1998; 51:149-54.
34. Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA. Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis 2004; 39:1129-35.
35. Aziz N, Baron EJ, D'Souza H, Nourbakhsh M, Druzin ML, Benitz WE. Comparison of rapid intrapartum screening methods for group B streptococcal vaginal colonization. J Matern Fetal Neonatal Med 2005; 18:225-9.
36. Haberland CA, Benitz WE, Sanders GD, et al. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics 2002; 110:471-80.
37. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999; 103:e77.
38. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22.
39. Centers for Disease Control and Prevention. Diminishing racial disparities in early-onset neonatal group B streptococcal disease-United States, 2000-2003. MMWR Morb Mortal Wkly Rep 2004; 53:502-5.
40. Lawson AJ. Discovering new pathogens: culture-resistant bacteria. Methods Mol Biol 2004; 266:305-22.
41. Chi H, Chiu NC, Li WC, Huang FY. Etiology of acute pharyngitis in children: is antibiotic therapy needed? J Microbiol Immunol Infect 2003; 36:26-30.
42. Duggan C, Santosham M, Glass RI. The management of acute diarrhea in children: oral rehydration, maintenance, and nutritional therapy. Centers for Disease Control and Prevention. MMWR Recomm Rep 1992; 41(RR-16):1-20.
43. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000; 31:347-82.
44. Heller MJ. DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng 2002; 4:129-53.
45. Campbell CJ, Ghazal P. Molecular signatures for diagnosis of infection: application of microarray technology. J Appl Microbiol 2004; 96:18-23.
46. Piersanti S, Martina Y, Cherubini G, Avitabile D, Saggio I. Use of DNA microarrays to monitor host response to virus and virus-derived gene therapy vectors. Am J Pharmacogenomics 2004; 4:345-56.
47. Ren Q, Robertson SJ, Howe D, Barrows LF, Heinzen RA. Comparative DNA microarray analysis of host cell transcriptional responses to infection by Coxiella burnetii or Chlamydia trachomatis. Ann N Y Acad Sci 2003; 990:701-13.
48. Draghici S, Chen D, Reifman J. Applications and challenges of DNA microarray technology in military medical research. Mil Med 2004; 169:654-9.
49. Brazas MD, Hancock RE. Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. Drug Discov Today 2005; 10:1245-52.
50. Breitling R, Amtmann A, Herzyk P. Iterative group analysis (iGA): a simple tool to enhance sensitivity and facilitate interpretation of microarray experiments. BMC Bioinformatics 2004; 5:34.